A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions

DIPG

Interventions

DRUG

Bevacizumab Injection

Additional concurrent low-dose Bevacizumab with standard EBRT

RADIATION

Ultra-low-dose RT

Ultra-low-dose EBRT instead of standard dose RT

Trial Locations (1)

RECRUITING

Tata Memorial Hospital, Mumbai

All Listed Sponsors

lead

Tata Memorial Centre

OTHER